Shares of Novartis were climbing higher on Friday after the Food and Drug Administration (FDA) approved Novartis’ $2.1 million gene therapy Zolgensma. Zolgensma is a one-time treatment for spinal muscular atrophy and is the world’s most expensive drug now. Previously Novartis had said that the treatment could cost anywhere from $1.5 to $5 million but … Continue reading “Novartis’ Gene Therapy Gets Nod from FDA”
Tag: gene therapy
Biotech & Pharma
The First FDA Approved Therapy to Fight Leukemia is Here
The FDA has approved a gene therapy treatment for use in the U.S to Novartis…
August 30, 2017